Variable | Non-metformin users | Metformin users | P value | Overall |
n | 287 | 645 | – | 932 |
Age (years) | 39.77±14.95 | 51.16±14.64 | <0.0001 | 47.66±15.64 |
Gender | ||||
Male | 157 (54.7%) | 280 (43.4%) | 0.001 | 437 (46.9%) |
Female | 130 (45.3%) | 365 (56.6%) | 495 (53.1%) | |
Marital status | ||||
Single | 68 (23.7%) | 12 (1.9%) | <0.0001 | 80 (8.6%) |
Married | 219 (76.3%) | 633 (98.1%) | 852 (91.4%) | |
Duration of DM (years) | – | 8.03±5.4 | – | 8.03±5.4 |
BMI (kg/m2) | 26.03±5.42 | 27.91±5.12 | <0.0001 | 27.36±5.28 |
Systolic blood pressure (mm Hg) | 126.94±18.06 | 134.41±18.58 | <0.0001 | 132.2±18.73 |
Diastolic blood pressure (mm Hg) | 78±14.6 | 81.61±13.62 | 0.001 | 80.54±14.01 |
Sulfonylureas | – | 119 (18.44%) | 119 (18.44%) | |
Thiazide diuretics | – | 39 (6.06%) | 39 (6.06%) | |
Dipeptidyl peptidase-4 (DPP4) inhibitor | – | 164 (25.4%) | 164 (25.4%) | |
Hb (g/dL) | 14.05±2.3 | 13.41±2.32 | <0.0001 | 13.61±2.33 |
Data presented as n (%) or mean±SD.
Student’s t-test and χ2 test were applied.
P<0.05 considered to be statistically significant.
BMI, body mass index; DM, diabetes mellitus.